Framework for the supply of Radiopharmaceuticals and Related Consumables - 2023

Description

HealthTrust Europe (HTE) is seeking to establish a multi-Lot framework agreement for the supply of Radiopharmaceuticals, which are sterile and non-sterile radioactive drugs used in nuclear medicine procedures to diagnose, monitor, and treat diseases. Lot 1: Agreement with Access Pricing via Direct Award for the Supply of Radiopharmaceuticals Components and Consumables Suppliers must possess the ability and all applicable licences to obtain, store and deliver and dispose of Radiopharmaceutical Goods in accordance with Legislation, Regulation and Procedural Best Practice. Goods included within the scope of Lot 1: • Radio-active components; • Non-radioactive components (kits) for combination with a radioactive component; • Radionuclide generators; • Precursors used for radiolabelling other substances prior to administration. Lot 2: Agreement with Access Pricing via Direct Award for the Supply of Patient Specific Radiopharmaceuticals Suppliers must possess the capability and the licences to provide an outsourced service to prepare ready for use’ Radiopharmaceuticals which meet individual patient specifications. Suppliers must also possess the ability and the licences to obtain, compound, store, deliver and dispose of Goods in accordance with Legislation, Regulation and Procedural Best Practice.